CEMIP and colorectal adenocarcinoma: The aim of this study was to characterise the KIAA1199 transcript and protein expression in colorectal adenocarcinomas, the correlation of KIAA1199 expression with patient outcome and the identification of KIAA1199-related pathways to elucidate the role of KIAA1199 in CRC.